Literature DB >> 15534625

CYP2A6 genetic polymorphisms and correlation with smoking status in Brazilians.

G M Vasconcelos1, C J Struchiner, G Suarez-Kurtz.   

Abstract

We investigated polymorphisms of cytochrome P450 2A6 (CYP2A6) and its association with smoking habits in 412 healthy Brazilians, self-recognized as white (n=147), black (n=123) and intermediate (n=142), and classified as smokers (n=205, including 61 ex-smokers) and nonsmokers (n=207). The frequencies of the variant alleles CYP2A6(*)1B, CYP2A6(*)2, CYP2A6(*)4 and CYP2A6(*)9 in the overall study population were 29.9, 1.7, 0.5 and 5.7%, respectively. Significant differences in the CYP2A6 allelic distribution were observed across the three population subgroups. There was a statistically significant trend for decreasing frequency of CYP2A6(*)1B from white to intermediate and to black persons. An association between CYP2A6 genotype and smoking dependence was detected, which could not be explained by the expected phenotypic activity of CYP2A6. In white and intermediate persons, the odds ratio (OR) of being smokers vs nonsmokers was 0.07 (95% CI 0.02-0.20; P<0.001) and 0.27 (95% CI 0.12-0.61; P<0.001), respectively, for genotypes including allele CYP2A6(*)1B, as compared to wild-type homozygous. In contrast, the corresponding OR in black Brazilians was 1.34 (95% CI 0.57-3.17; P=0.46). These data suggest that the CYP2A6(*)1B is associated with smoking dependence in white and intermediate, but not black Brazilians.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15534625     DOI: 10.1038/sj.tpj.6500290

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


  9 in total

1.  CYP2A6 deletion polymorphism is associated with decreased susceptibility of lung cancer in Asian smokers: a meta-analysis.

Authors:  Yu-liang Liu; Yu Xu; Fan Li; Hong Chen; Shu-liang Guo
Journal:  Tumour Biol       Date:  2013-05-07

2.  In vivo evaluation of CYP2A6 and xanthine oxidase enzyme activities in the Serbian population.

Authors:  Natasa Djordjevic; Juan Antonio Carrillo; Guillermo Gervasini; Slobodan Jankovic; Eleni Aklillu
Journal:  Eur J Clin Pharmacol       Date:  2010-02-13       Impact factor: 2.953

3.  New CYP2A6 gene deletion and conversion variants in a population of Black African descent.

Authors:  Jill C Mwenifumbo; Qian Zhou; Neal L Benowitz; Edward M Sellers; Rachel F Tyndale
Journal:  Pharmacogenomics       Date:  2010-02       Impact factor: 2.533

4.  Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genes.

Authors:  Alec W R Langlois; Ahmed El-Boraie; Koya Fukunaga; Taisei Mushiroda; Michiaki Kubo; Caryn Lerman; Jo Knight; Steven E Scherer; Meghan J Chenoweth; Rachel F Tyndale
Journal:  Pharmacogenet Genomics       Date:  2022-02-21       Impact factor: 2.000

5.  Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism.

Authors:  J C Mwenifumbo; C N Lessov-Schlaggar; Q Zhou; R E Krasnow; G E Swan; N L Benowitz; R F Tyndale
Journal:  Clin Pharmacol Ther       Date:  2007-05-23       Impact factor: 6.875

Review 6.  Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction.

Authors:  Luis A López-Flores; Gloria Pérez-Rubio; Ramcés Falfán-Valencia
Journal:  EXCLI J       Date:  2017-03-06       Impact factor: 4.068

7.  Association of CYP2A6*4 with susceptibility of lung cancer: a meta-analysis.

Authors:  Lishan Wang
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

8.  Association of genetic polymorphisms CYP2A6*2 rs1801272 and CYP2A6*9 rs28399433 with tobacco-induced lung Cancer: case-control study in an Egyptian population.

Authors:  Nada Ezzeldin; Dalia El-Lebedy; Amira Darwish; Ahmed El Bastawisy; Shereen Hamdy Abd Elaziz; Mirhane Mohamed Hassan; Amal Saad-Hussein
Journal:  BMC Cancer       Date:  2018-05-03       Impact factor: 4.430

Review 9.  Methods for smoking cessation and treatment of nicotine dependence.

Authors:  Aracy Pereira Silveira Balbani; Jair Cortez Montovani
Journal:  Braz J Otorhinolaryngol       Date:  2005 Nov-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.